Navigation Links
Some People With Alzheimer's Take Conflicting Drugs
Date:10/28/2011

FRIDAY, Oct. 28 (HealthDay News) -- Many Alzheimer's patients who take cholinesterase inhibitors to slow their brain disease also take drugs that counter the effects of those Alzheimer's medications, a new study says.

Clinical trials have shown that cholinesterase inhibitors such as Aricept (donepezil) have a modest impact on the functional and cognitive decline caused by Alzheimer's disease, noted the researchers at the Group Health Research Institute in Seattle.

"Cholinesterase inhibitors are today's primary therapy for slowing Alzheimer's disease," study leader Denise Boudreau said in an institute news release.

"Anticholinergic properties are often found in drugs commonly used to treat gastrointestinal disorders, allergies, urinary incontinence, depression and Parkinson's disease, and they can have negative effects on cognition and function in the elderly. There's concern that if someone is taking both types of drugs -- cholinesterase inhibitors and anticholinergic medications -- they will antagonize each other, and neither will work," she explained.

Common anticholinergic medications include Benadryl (diphenhydramine) and Ditropan (oxybutynin), which is prescribed for overactive bladders.

Boudreau and colleagues analyzed data from more than 5,600 patients aged 50 and older who had cholinesterase inhibitors prescribed to them for the first time between 2000 and 2007. Of those patients, 37 percent also took at least one anticholinergic drug and more than 11 percent took two or more anticholinergic drugs.

Among the patients who took both classes of drugs, dual use generally lasted three to four months, but one-quarter of the patients used both classes of drugs for more than a year.

The researchers also found that 23 percent of patients who received a new prescription for cholinesterase inhibitors were already using at least one anticholinergic drug, and 77 percent of those patients continued taking an anticholinergic drug after they began taking a cholinesterase inhibitor.

"It's reassuring that we did not observe an association between simultaneous use of the two types of drugs and increased risk of death or nursing home placement," Boudreau said in the release. "But concomitant use of these drugs is, at the very least, not optimal clinical practice."

The study was published online Oct. 22 in the Journal of the American Geriatrics Society.

Alzheimer's patients often have multiple health problems, which may help explain why doctors might prescribe conflicting medications for these patients, the researchers said.

More information

The U.S. National Institute on Aging has more about Alzheimer's medications.

-- Robert Preidt

SOURCE: Group Health Research Institute, news release, Oct. 25, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Obese people regain weight after dieting due to hormones
2. Multiple malaria vaccine offers protection to people most at risk
3. Computer games help people with Parkinsons disease
4. People With Mental Health Issues More Likely to Be Uninsured
5. Researcher identifies autism employment resources, tips for people with autism spectrum disorders
6. We discount the pain of people we dont like
7. Older people are happier in Brazil and South Africa
8. Easily embarrassed? Study finds people will trust you more
9. First detection of pregnancy protein in older people destined for Alzheimers disease
10. People learn while they sleep, study suggests
11. Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Some People With Alzheimer's Take Conflicting Drugs
(Date:9/24/2017)... ... September 24, 2017 , ... “Star of Bethlehem Study”: is a thought-provoking ... the creation of published author, Duane Engdahl, an investigator who had has a long ... Duane Engdahl’s new book is a thought-provoking essay an event so significant that it ...
(Date:9/23/2017)... ... September 23, 2017 , ... Silicon Valley Hair Institute, the ... a new blog post focused on the ARTAS® hair transplant system and the younger ... to the latest, most technologically sophisticated methods of hair restoration. , “It can be ...
(Date:9/22/2017)... ... September 22, 2017 , ... On Sunday, September 24, hundreds ... honoring Olympian, Florence Joyner, still considered the fastest woman of all time. Flo ... daughter, Mary Joyner, will sing the National Anthem. Mary was a contestant on ...
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor , a construction ... Architect (RPA), a full-service architecture firm focusing on sustainable design, have announced ... Model Homes . Independently, Ecocor and RPA have extensive experience with site-built and ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from Sonora, California, ... Leadership and Administration at St. Thomas University in Miami, Florida, was selected from ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... Va. , Aug. 29, 2017 ivWatch, LLC, the ... peripheral IV infiltrations, announced it has been awarded an Innovative Technology ... company in the country. ... continuous monitoring device to aid in the early detection of peripheral ... The Innovative ...
Breaking Medicine Technology: